Search results
I-Mab and BMS assess givastomig for gastric and oesophageal cancer
Pharmaceutical Technology via Yahoo Finance· 35 minutes agoGivastomig is under investigation in a Phase I trial in the US and China. The US Food and Drug ...
Cancer Drugs: Deals and Licensing for Antibody-Drug Conjugates
The National Law Review· 12 hours agoAntibody-drug conjugates (ADCs) are a promising class of cancer treatments with an accelerating...
Lung Cancer Was a Death Sentence. Now Drugs Are Saving Lives.
The Wall Street Journal· 4 days agoMore patients can fend off the disease for months or years with targeted or immune-boosting drugs,...
Cancer-fighting antibodies inject chemo directly into tumor cells, upping effectiveness
NBC NEWS· 4 days agoThe approach isn’t entirely new: The first antibody drug conjugate was approved by the Food and Drug...
Can-Fite's Namodenoson gains FDA Fast Track for liver cancer By Investing.com
Investing.com· 20 hours agoFood and Drug Administration (FDA) for the treatment of advanced liver cancer, also known as...
FDA confirms robotic prostatectomy survival rates match traditional surgery By Investing.com
Investing.com· 16 hours agoThe U.S. Food and Drug Administration (FDA) has approved a labeling revision for Intuitive's da...
DermaSensor COO on bringing skin cancer detection device to market - South Florida Business Journal
The Business Journals· 17 hours agoAfter years of development, DermaSensor's handheld skin cancer detection tool is now in the hands of...
Sodas sold in restaurants across the country recalled over dye linked to cancer: FDA
Local 12 Cincinnati· 6 hours agoA soda company has recalled several products that were sold in restaurants across the country....
New report reveals concerning levels of contaminant found in products of several popular olive oil...
The Cool Down via Yahoo News· 18 hours agoTwo petitions were rejected by the FDA...
ASCO 2024: Alligator shares positive data for pancreatic cancer drug
Pharmaceutical Technology via Yahoo Finance· 2 days agoBregenholt explains that for 80% of pancreatic cancer patients, the only option available for...